Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 1/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21392634 | 0.93 | GPR3 (0.37) | ALKGPR3PDK2MAPTALDH1A1 | |
| SCHEMBL18164897 | 0.92 | GPR3 (0.31) | GPR3PDK2MAPTALDH1A1POLB | |
| SCHEMBL16124274 | 0.92 | PDK2 (0.36) | ALKGPR3PDK2MAPTALDH1A1 | |
| SCHEMBL905072 | 0.91 | PDK2 (0.32) | ALKPDK2 | |
| SCHEMBL22057726 | 0.91 | ALDH1A1 (0.36) | ALKGPR3PDK2MAPTALDH1A1 | |
| SCHEMBL21141221 | 0.90 | GPR3 (0.34) | ALKGPR3PDK2MAPTALDH1A1 | |
| SCHEMBL17690168 | 0.90 | GPR3 (0.34) | ALKGPR3PDK2MAPTALDH1A1 | |
| SCHEMBL16883233 | 0.90 | GPR3 (0.34) | ALKGPR3PDK2MAPTALDH1A1 | |
| SCHEMBL17126481 | 0.89 | PDK2 (0.32) | ALKGPR3PDK2MAPTALDH1A1 | |
| SCHEMBL16124271 | 0.89 | PDK2 (0.32) | ALKGPR3PDK2MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3596066-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2022-05-18 | — | — | EP | disclosed |
| US-20200152883-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-05-14 | — | — | US | disclosed |
| CN-103889945-A | New triphenylene derivative and organic electroluminescent element using said derivative [9, 10] | HODOGAYA CHEMICAL CO LTD | 2014-06-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200152883-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | DDT, TRDMT1, ESD | ALK 3400/4885GPR3 4607/4885PDK2 1021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.